Lacticaseibacillus rhamnosus GG and Saccharomyces cerevisiae boulardii supplementation exert protective effects on human gut microbiome following antibiotic administration in vitro
In: Beneficial MicrobesSearch for other papers by C. Duysburgh in
Current site
Google Scholar
Search for other papers by P. Van den Abbeele in
Current site
Google Scholar
Search for other papers by M. Morera in
Current site
Google Scholar
Center of Microbial Ecology and Technology (CMET), Ghent University, Coupure Links 653, 9000 Ghent, Belgium.
Search for other papers by M. Marzorati in
Current site
Google Scholar
Antibiotic-induced dysbiosis of the microbial community has been associated with several gastrointestinal symptoms. The impact of repeated administration of Lacticaseibacillus rhamnosus GG (CNCM-I-4798) (formerly known as Lactobacillus rhamnosus GG), Saccharomyces cerevisiae boulardii (CNCM-I-1079) and their combination (associated in Smebiocta/Smectaflora Protect®) in supporting recovery of gut microbiota functionality and composition during and following amoxicillin:clavulanic acid administration was evaluated in vitro. Antibiotic dosage negatively affected SCFA production, coinciding with detrimental effects on Bacteroidetes, Firmicutes and Bifidobacterium spp. in the simulated proximal colon, while Akkermansia muciniphila was significantly reduced in the distal colon. L. rhamnosus GG and S. boulardii were able to thrive in both colon regions upon dosing, with S. boulardii even showing protective effects on the survival of L. rhamnosus GG during antibiotic administration. The impact of the probiotic strains on microbiome recovery revealed that supplementation with L. rhamnosus GG and/or S. boulardii resulted in a stimulating effect on the most abundant bacterial groups within the bacterial community of each donor. For one of the donors tested, co-dosing of L. rhamnosus GG and S. boulardii resulted in superior short-chain fatty acid recovery accompanied by a stronger increase in abundance of Bifidobacteriaceae. Overall, the current study provides first evidence that combined supplementation of L. rhamnosus GG and S. boulardii might be an interesting candidate in limiting detrimental effects of amoxicillin:clavulanic acid on the human gut microbiome, though further studies are warranted to confirm these findings.
-
Agamennone, V., Krul, C.A.M., Rijkers, G. and Kort, R., 2018. A practical guide for probiotics applied to the case of antibiotic-associated diarrhea in the Netherlands. BMC Gastroenterology 18: 103.
'A practical guide for probiotics applied to the case of antibiotic-associated diarrhea in the Netherlands ' () 18 BMC Gastroenterology : 103.
-
Barc, M.C., Bourlioux, F., Rigottier-Gois, L., Charrin-Sarnel, C., Janoir, C., Boureau, H., Dore, J. and Collignon, A., 2004. Effect of amoxicillin-clavulanic acid on human fecal flora in a gnotobiotic mouse model assessed with fluorescence hybridization using group-specific 16S rRNA probes in combination with flow cytometry. Antimicrobial Agents and Chemotherapy 48: 1365-1368.
'Effect of amoxicillin-clavulanic acid on human fecal flora in a gnotobiotic mouse model assessed with fluorescence hybridization using group-specific 16S rRNA probes in combination with flow cytometry ' () 48 Antimicrobial Agents and Chemotherapy : 1365 -1368.
-
Boon, N., Top, E.M., Verstraete, W. and Siciliano, S.D., 2003. Bioaugmentation as a tool to protect the structure and function of an activated-sludge microbial community against a 3-chloroaniline shock load. Applied and Environmental Microbiology 69: 1511-1520.
'Bioaugmentation as a tool to protect the structure and function of an activated-sludge microbial community against a 3-chloroaniline shock load ' () 69 Applied and Environmental Microbiology : 1511 -1520.
-
Brötz-Oesterhelt, H. and Brunner, N.A., 2008. How many modes of action should an antibiotic have? Current Opinion in Pharmacology 8: 564-573.
'How many modes of action should an antibiotic have? ' () 8 Current Opinion in Pharmacology : 564 -573.
-
Capurso, L., 2019. Thirty years of Lactobacillus rhamnosus GG: a review. Journal of Clinical Gastroenterology 53: S1-S41.
'Thirty years of Lactobacillus rhamnosus GG: a review ' () 53 Journal of Clinical Gastroenterology : S1 -S41.
-
Collado, M.C., Derrien, M., Isolauri, E., de Vos, W.M. and Salminen, S., 2007. Intestinal integrity and Akkermansia muciniphila, a mucin-degrading member of the intestinal microbiota present in infants, adults, and the elderly. Applied and Environmental Microbiology 73: 7767-7770.
'Intestinal integrity and Akkermansia muciniphila, a mucin-degrading member of the intestinal microbiota present in infants, adults, and the elderly ' () 73 Applied and Environmental Microbiology : 7767 -7770.
-
Daguet, D., Pinheiro, I., Verhelst, A., Possemiers, S. and Marzorati, M., 2016. Arabinogalactan and fructooligosaccharides improve the gut barrier function in distinct areas of the colon in the simulator of the human intestinal microbial ecosystem. Journal of Functional Foods 20: 369-379.
'Arabinogalactan and fructooligosaccharides improve the gut barrier function in distinct areas of the colon in the simulator of the human intestinal microbial ecosystem ' () 20 Journal of Functional Foods : 369 -379.
-
De Keersmaecker, S.C., Verhoeven, T.L., Desair, J., Marchal, K., Vanderleyden, J. and Nagy, I., 2006. Strong antimicrobial activity of Lactobacillus rhamnosus GG against Salmonella Typhimurium is due to accumulation of lactic acid. FEMS Microbiology Letters 259: 89-96.
'Strong antimicrobial activity of Lactobacillus rhamnosus GG against Salmonella Typhimurium is due to accumulation of lactic acid ' () 259 FEMS Microbiology Letters : 89 -96.
-
De La Cochetière, M.F., Durand, T., Lepage, P., Bourreille, A., Galmiche, J.P. and Doré, J., 2005. Resilience of the dominant human fecal microbiota upon short-course antibiotic challenge. Journal of Clinical Microbiology 43: 5588-5592.
'Resilience of the dominant human fecal microbiota upon short-course antibiotic challenge ' () 43 Journal of Clinical Microbiology : 5588 -5592.
-
De Velde, F., de Winter, B.C., Koch, B.C., van Gelder, T. and Mouton, J.W., 2016. Non-linear absorption pharmacokinetics of amoxicillin: consequences for dosing regimens and clinical breakpoints. Journal of Antimicrobial Chemotherapy 71: 2909-2917.
'Non-linear absorption pharmacokinetics of amoxicillin: consequences for dosing regimens and clinical breakpoints ' () 71 Journal of Antimicrobial Chemotherapy : 2909 -2917.
-
De Weirdt, R., Possemiers, S., Vermeulen, G., Moerdijk-Poortvliet, T.C.W., Boschker, H.T.S., Verstraete, W. and Van de Wiele, T., 2010. Human faecal microbiota display variable patterns of glycerol metabolism. FEMS Microbiology Ecology 74: 601-611.
'Human faecal microbiota display variable patterns of glycerol metabolism ' () 74 FEMS Microbiology Ecology : 601 -611.
-
Dupont, D., Alric, M., Blanquet-Diot, S., Bornhorst, G., Cueva, C., Deglaire, A., Denis, S., Ferrua, M., Havenaar, R., Lelieveld, J., Mackie, A.R., Marzorati, M., Menard, O., Minekus, M., Miralles, B., Recio, I. and Van den Abbeele, P., 2019. Can dynamic in vitro digestion systems mimic the physiological reality? Critical Reviews in Food Science and Nutrition 59: 1546-1562.
'Can dynamic in vitro digestion systems mimic the physiological reality? ' () 59 Critical Reviews in Food Science and Nutrition : 1546 -1562.
-
Duysburgh, C., Van Den Abbeele, P., Bothe, M., Stover, J., Kuchinka-Koch, A., Schwejda-Guettes, S. and Marzorati, M., 2019a. Lactulose crystals beneficially affect community composition along entire human colon in vitro, resulting in donor-dependent prebiotic effects at metabolic level. International Journal of Nutrition and Food Sciences 8: 10.
'Lactulose crystals beneficially affect community composition along entire human colon in vitro, resulting in donor-dependent prebiotic effects at metabolic level ' () 8 International Journal of Nutrition and Food Sciences : 10.
-
Duysburgh, C., Van den Abbeele, P., Krishnan, K., Bayne, T.F. and Marzorati, M., 2019b. A synbiotic concept containing spore-forming Bacillus strains and a prebiotic fiber blend consistently enhanced metabolic activity by modulation of the gut microbiome in vitro. International Journal of Pharmaceutics: X 1: 100021.
'A synbiotic concept containing spore-forming Bacillus strains and a prebiotic fiber blend consistently enhanced metabolic activity by modulation of the gut microbiome in vitro ' () 1 International Journal of Pharmaceutics: X : 100021.
-
Eckburg, P.B., Bik, E.M., Bernstein, C.N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S.R., Nelson, K.E. and Relman, D.A., 2005. Diversity of the human intestinal microbial flora. Science 308: 1635-1638.
'Diversity of the human intestinal microbial flora ' () 308 Science : 1635 -1638.
-
Ehrhardt, S., Guo, N., Hinz, R., Schoppen, S., May, J., Reiser, M., Schroeder, M.P., Schmiedel, S., Keuchel, M., Reisinger, E.C., Langeheinecke, A., de Weerth, A., Schuchmann, M., Schaberg, T., Ligges, S., Eveslage, M., Hagen, R.M., Burchard, G.D., Lohse, A.W., Group, f.t.S.S., Ruf, B., Porschen, R., Trenn, G., Butterfaβ-Bahloul, T., Wuerthwein, G., Oeder, F., Runge, A., Klauss, E., Hansen-Rosenblatt, N., Werner, T., Schulze, K., Kreuels, B., Schäfer, G., Hübener, P., Hennigs, A., Beisel, C., Fischer-Brügge, D., Zimmermann-Fraedrich, K., Röder, C., Grigo, N., Riecke, A., Schreckenbauer, H., Hemmer, C., Klammt, S., Geerdes-Fenge, H., Frimmel, S., Kittner, J.M., Rey, J.W., Schattenberg, J.M., Thieringer, F., Schmits, R., Grandt, D., Büch, P.M., Klebert, A., Mittag, M.A., Lehnen, S., Tiefengraber, D., Radecke, K., Hering, I., Zeller, W., Rundt, L., Brandt, L., Baltes, P., Dajani, D., Kurniawan, N., Pflüger, C., Behjat, N., Engel, U., Unger, M. and Group, f.t.S.S., 2016. Saccharomyces boulardii to prevent antibiotic-associated diarrhea: a randomized, double-masked, placebo-controlled trial. Open Forum Infectious Diseases 3: ofw011.
'Saccharomyces boulardii to prevent antibiotic-associated diarrhea: a randomized, double-masked, placebo-controlled trial ' () 3 Open Forum Infectious Diseases : ofw011.
-
European Agency for the Evaluation of Medicinal Products (EMEA), 2001. Clavulanic acid. Report EMEA/MRL/776?01-Final. Committee for Veterinary Medicinal Products, London, pp. 1-6.
-
European Center for Disease Prevention and Control, 2018. Antimicrobial consumption – Annual Epidemiological Report for 2017. Annual Epidemiological Report on Ciommunicable Diseases in Europe. ECDC, Stockholm, Sweden.
-
Furet, J.P., Firmesse, O., Gourmelon, M., Bridonneau, C., Tap, J., Mondot, S., Dore, J. and Corthier, G., 2009. Comparative assessment of human and farm animal faecal microbiota using real-time quantitative PCR. FEMS Microbiology Ecology 68: 351-362.
'Comparative assessment of human and farm animal faecal microbiota using real-time quantitative PCR ' () 68 FEMS Microbiology Ecology : 351 -362.
-
Guarner, F., Sanders, M.E., Eliakim, R., Fedorak, R., Gangl, A., Garisch, J., Kaufmann, P., Karakan, T., Khan, A.G. and Kim, N., 2017. Probiotics and prebiotics. World Gastroenterology Organisation Global Guidelines. World Gastroenterology Organisation, Milwaukee, WI, USA. Available at: https://tinyurl.com/4sapeppc
-
Guo, X., Xia, X., Tang, R., Zhou, J., Zhao, H. and Wang, K., 2008. Development of a real-time PCR method for Firmicutes and Bacteroidetes in faeces and its application to quantify intestinal population of obese and lean pigs. Letters in Applied Microbiology 47: 367-373.
'Development of a real-time PCR method for Firmicutes and Bacteroidetes in faeces and its application to quantify intestinal population of obese and lean pigs ' () 47 Letters in Applied Microbiology : 367 -373.
-
Hartemink, R., Domenech, V.R. and Rombouts, F.M., 1997. LAMVAB – A new selective medium for the isolation of lactobacilli from faeces. Journal of Microbiological Methods 29: 77-84.
'LAMVAB – A new selective medium for the isolation of lactobacilli from faeces ' () 29 Journal of Microbiological Methods : 77 -84.
-
Hill, C., Guarner, F., Reid, G., Gibson, G.R., Merenstein, D.J., Pot, B., Morelli, L., Canani, R.B., Flint, H.J., Salminen, S., Calder, P.C. and Sanders, M.E., 2014. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology and Hepatology 11: 506-514.
'Expert consensus document ' () 11 Nature Reviews Gastroenterology and Hepatology : 506 -514.
-
Kalliomaki, M., Salminen, S., Arvilommi, H., Kero, P., Koskinen, P. and Isolauri, E., 2001. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. The Lancet 357: 1076-1079.
'Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial ' () 357 The Lancet : 1076 -1079.
-
Klindworth, A., Pruesse, E., Schweer, T., Peplies, J., Quast, C., Horn, M. and Glockner, F.O., 2013. Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies. Nucleic Acids Research 41: e1.
'Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies ' () 41 Nucleic Acids Research : e1.
-
Kotowska, M., Albrecht, P. and Szajewska, H., 2005. Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial. Alimentary Pharmacology and Therapeutics 21: 583-590.
'Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial ' () 21 Alimentary Pharmacology and Therapeutics : 583 -590.
-
Kozich, J.J., Westcott, S.L., Baxter, N.T., Highlander, S.K. and Schloss, P.D., 2013. Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform. Applied and Environmental Microbiology 79: 5112-5120.
'Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform ' () 79 Applied and Environmental Microbiology : 5112 -5120.
-
Ladirat, S.E., Schoterman, M.H., Rahaoui, H., Mars, M., Schuren, F.H., Gruppen, H., Nauta, A. and Schols, H.A., 2014a. Exploring the effects of galacto-oligosaccharides on the gut microbiota of healthy adults receiving amoxicillin treatment. British Journal of Nutrition 112: 536-546.
'Exploring the effects of galacto-oligosaccharides on the gut microbiota of healthy adults receiving amoxicillin treatment ' () 112 British Journal of Nutrition : 536 -546.
-
Ladirat, S.E., Schuren, F.H., Schoterman, M.H., Nauta, A., Gruppen, H. and Schols, H.A., 2014b. Impact of galacto-oligosaccharides on the gut microbiota composition and metabolic activity upon antibiotic treatment during in vitro fermentation. FEMS Microbiology Ecology 87: 41-51.
'Impact of galacto-oligosaccharides on the gut microbiota composition and metabolic activity upon antibiotic treatment during in vitro fermentation ' () 87 FEMS Microbiology Ecology : 41 -51.
-
Lazo-Vélez, M.A., Serna-Saldívar, S.O., Rosales-Medina, M.F., Tinoco-Alvear, M. and Briones-García, M., 2018. Application of Saccharomyces cerevisiae var. boulardii in food processing: a review. Journal of Applied Microbiology 125: 943-951.
'Application of Saccharomyces cerevisiae var. boulardii in food processing: a review ' () 125 Journal of Applied Microbiology : 943 -951.
-
Legen, I., Kracun, M., Salobir, M. and Kerc, J., 2006. The evaluation of some pharmaceutically acceptable excipients as permeation enhancers for amoxicillin. International Journal of Pharmaceutics 308: 84-89.
'The evaluation of some pharmaceutically acceptable excipients as permeation enhancers for amoxicillin ' () 308 International Journal of Pharmaceutics : 84 -89.
-
Liu, L., Firrman, J., Tanes, C., Bittinger, K., Thomas-Gahring, A., Wu, G.D., Van den Abbeele, P. and Tomasula, P.M., 2018. Establishing a mucosal gut microbial community in vitro using an artificial simulator. PLoS ONE 13: e0197692.
'Establishing a mucosal gut microbial community in vitro using an artificial simulator ' () 13 PLoS ONE : e0197692.
-
Mantegazza, C., Molinari, P., D’Auria, E., Sonnino, M., Morelli, L. and Zuccotti, G.V., 2018. Probiotics and antibiotic-associated diarrhea in children: a review and new evidence on Lactobacillus rhamnosus GG during and after antibiotic treatment. Pharmacological Research 128: 63-72.
'Probiotics and antibiotic-associated diarrhea in children: a review and new evidence on Lactobacillus rhamnosus GG during and after antibiotic treatment ' () 128 Pharmacological Research : 63 -72.
-
McFarland, L.V., 2008. Antibiotic-associated diarrhea: epidemiology, trends and treatment. Future Microbiology 3: 563-578.
'Antibiotic-associated diarrhea: epidemiology, trends and treatment ' () 3 Future Microbiology : 563 -578.
-
McFarland, L.V. and Elmer, G.W., 2005. Properties of evidence-based probiotics for human health. In: Goktepe, I., Juneja, V.K. and Ahmedna, M. (eds.) Probiotics in food safety and human health. CRC Press, Boca Raton, FL, USA, pp. 110-128.
'Properties of evidence-based probiotics for human health ', () 110 -128.
-
McFarland, L.V., Surawicz, C.M., Greenberg, R.N., Elmer, G.W., Moyer, K.A., Melcher, S.A., Bowen, K.E. and Cox, J.L., 1995. Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo. American Journal of Gastroenterology 90: 439-448.
'Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo ' () 90 American Journal of Gastroenterology : 439 -448.
-
Minekus, M., Alminger, M., Alvito, P., Ballance, S., Bohn, T., Bourlieu, C., Carrière, F., Boutrou, R., Corredig, M., Dupont, D., Dufour, C., Egger, L., Golding, M., Karakaya, S., Kirkhus, B., Le Feunteun, S., Lesmes, U., Macierzanka, A., Mackie, A., Marze, S., McClements, D.J., Ménard, O., Recio, I., Santos, C.N., Singh, R.P., Vegarud, G.E., Wickham, M.S., Weitschies, W. and Brodkorb, A., 2014. A standardised static in vitro digestion method suitable for food – an international consensus. Food and Function 5: 1113-1124.
'A standardised static in vitro digestion method suitable for food – an international consensus ' () 5 Food and Function : 1113 -1124.
-
Minekus, M., Smeets-Peeters, M., Bernalier, A., Marol-Bonnin, S., Havenaar, R., Marteau, P., Alric, M., Fonty, G. and Huis in’t Veld, J.H., 1999. A computer-controlled system to simulate conditions of the large intestine with peristaltic mixing, water absorption and absorption of fermentation products. Applied Microbiology and Biotechnology 53: 108-114.
'A computer-controlled system to simulate conditions of the large intestine with peristaltic mixing, water absorption and absorption of fermentation products ' () 53 Applied Microbiology and Biotechnology : 108 -114.
-
Moens, F., Duysburgh, C., van den Abbeele, P., Morera, M. and Marzorati, M., 2019. Lactobacillus rhamnosus GG and Saccharomyces cerevisiae boulardii exert synergistic antipathogenic activity in vitro against enterotoxigenic Escherichia coli. Beneficial Microbes 10: 923-935.
'Lactobacillus rhamnosus GG and Saccharomyces cerevisiae boulardii exert synergistic antipathogenic activity in vitro against enterotoxigenic Escherichia coli ' () 10 Beneficial Microbes : 923 -935.
-
Molly, K., Vande Woestyne, M. and Verstraete, W., 1993. Development of a 5-step multi-chamber reactor as a simulation of the human intestinal microbial ecosystem. Applied Microbiology and Biotechnology 39: 254-258.
'Development of a 5-step multi-chamber reactor as a simulation of the human intestinal microbial ecosystem ' () 39 Applied Microbiology and Biotechnology : 254 -258.
-
Moré, M.I. and Swidsinski, A., 2015. Saccharomyces boulardii CNCM I-745 supports regeneration of the intestinal microbiota after diarrheic dysbiosis – a review. Clinical and Experimental Gastroenterology 8: 237-255.
'Saccharomyces boulardii CNCM I-745 supports regeneration of the intestinal microbiota after diarrheic dysbiosis – a review ' () 8 Clinical and Experimental Gastroenterology : 237 -255.
-
Neut, C., Mahieux, S. and Dubreuil, L.J., 2017. Antibiotic susceptibility of probiotic strains: Is it reasonable to combine probiotics with antibiotics? Médecine et Maladies Infectieuses 47: 477-483.
'Antibiotic susceptibility of probiotic strains: Is it reasonable to combine probiotics with antibiotics? ' () 47 Médecine et Maladies Infectieuses : 477 -483.
-
Palleja, A., Mikkelsen, K., Forslund, S., Kashani, A., Allin, K., Nielsen, T., Hansen, T., Feng, Q., Zhang, C., Pyl, P., Coelho, L.P., Yang, H., Wang, J., Typas, A., Frost, M., Nielsen, H., Bork, P., Wang, J. and Pedersen, O., 2018. Recovery of gut microbiota of healthy adults following antibiotic exposure. Nature Microbiology 3: 1255-1265.
'Recovery of gut microbiota of healthy adults following antibiotic exposure ' () 3 Nature Microbiology : 1255 -1265.
-
Panda, S., El khader, I., Casellas, F., López Vivancos, J., García Cors, M., Santiago, A., Cuenca, S., Guarner, F. and Manichanh, C., 2014. Short-term effect of antibiotics on human gut microbiota. PLoS ONE 9: e95476.
'Short-term effect of antibiotics on human gut microbiota ' () 9 PLoS ONE : e95476.
-
Possemiers, S., Verthe, K., Uyttendaele, S. and Verstraete, W., 2004. PCR-DGGE-based quantification of stability of the microbial community in a simulator of the human intestinal microbial ecosystem. FEMS Microbiology Ecology 49: 495-507.
'PCR-DGGE-based quantification of stability of the microbial community in a simulator of the human intestinal microbial ecosystem ' () 49 FEMS Microbiology Ecology : 495 -507.
-
Pozzoni, P., Riva, A., Bellatorre, A.G., Amigoni, M., Redaelli, E., Ronchetti, A., Stefani, M., Tironi, R., Molteni, E.E., Conte, D., Casazza, G. and Colli, A., 2012. Saccharomyces boulardii for the prevention of antibiotic-associated diarrhea in adult hospitalized patients: a single-center, randomized, double-blind, placebo-controlled trial. American Journal of Gastroenterology 107: 922-931.
'Saccharomyces boulardii for the prevention of antibiotic-associated diarrhea in adult hospitalized patients: a single-center, randomized, double-blind, placebo-controlled trial ' () 107 American Journal of Gastroenterology : 922 -931.
-
Ramamurthy, D., Pazhani, G.P., Sarkar, A., Nandy, R.K., Rajendran, K., Sur, D., Manna, B. and Ramamurthy, T., 2013. Case-control study on the role of enterotoxigenic Bacteroides fragilis as a cause of diarrhea among children in Kolkata, India. PLoS ONE 8: e60622.
'Case-control study on the role of enterotoxigenic Bacteroides fragilis as a cause of diarrhea among children in Kolkata, India ' () 8 PLoS ONE : e60622.
-
Rinttila, T., Kassinen, A., Malinen, E., Krogius, L. and Palva, A., 2004. Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. Journal of Applied Microbiology 97: 1166-1177.
'Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR ' () 97 Journal of Applied Microbiology : 1166 -1177.
-
Schloss, P.D. and Westcott, S.L., 2011. Assessing and improving methods used in operational taxonomic unit-based approaches for 16S rRNA gene sequence analysis. Applied and Environmental Microbiology 77: 3219-3226.
'Assessing and improving methods used in operational taxonomic unit-based approaches for 16S rRNA gene sequence analysis ' () 77 Applied and Environmental Microbiology : 3219 -3226.
-
Soldi, S., Vasileiadis, S., Lohner, S., Uggeri, F., Puglisi, E., Molinari, P., Donner, E., Sieland, C., Decsi, T., Sailer, M. and Theis, S., 2019. Prebiotic supplementation over a cold season and during antibiotic treatment specifically modulates the gut microbiota composition of 3-6 year-old children. Beneficial Microbes 10: 253-263.
'Prebiotic supplementation over a cold season and during antibiotic treatment specifically modulates the gut microbiota composition of 3-6 year-old children ' () 10 Beneficial Microbes : 253 -263.
-
Sommer, F. and Bäckhed, F., 2013. The gut microbiota – masters of host development and physiology. Nature Reviews Microbiology 11: 227-238.
'The gut microbiota – masters of host development and physiology ' () 11 Nature Reviews Microbiology : 227 -238.
-
Spacova, I., O’Neill, C. and Lebeer, S., 2020. Lacticaseibacillus rhamnosus GG inhibits infection of human keratinocytes by Staphylococcus aureus through mechanisms involving cell surface molecules and pH reduction. Beneficial Microbes 11: 703-715.
'Lacticaseibacillus rhamnosus GG inhibits infection of human keratinocytes by Staphylococcus aureus through mechanisms involving cell surface molecules and pH reduction ' () 11 Beneficial Microbes : 703 -715.
-
Szajewska, H. and Kolodziej, M., 2015. Systematic review with meta-analysis: Lactobacillus rhamnosus GG in the prevention of antibiotic-associated diarrhoea in children and adults. Alimentary Pharmacology and Therapeutics 42: 1149-1157.
'Systematic review with meta-analysis: Lactobacillus rhamnosus GG in the prevention of antibiotic-associated diarrhoea in children and adults ' () 42 Alimentary Pharmacology and Therapeutics : 1149 -1157.
-
Tremblay, A., Fatani, A., Ford, A.L., Piano, A., Nagulesapillai, V., Auger, J., MacPherson, C.W., Christman, M.C., Tompkins, T.A. and Dahl, W.J., 2020. Safety and effect of a low- and high-dose multi-strain probiotic supplement on microbiota in a general adult population: a randomized, double-blind, placebo-controlled study. Journal of Dietary Suppl. 18: 227-247.
'Safety and effect of a low- and high-dose multi-strain probiotic supplement on microbiota in a general adult population: a randomized, double-blind, placebo-controlled study ' () 18 Journal of Dietary : 227 -247.
-
Tsitko, I., Wiik-Miettinen, F., Mattila, O., Rosa-Sibakov, N., Seppänen-Laakso, T., Maukonen, J., Nordlund, E. and Saarela, M., 2019. A small in vitro fermentation model for screening the gut microbiota effects of different fiber preparations. International Journal of Molecular Sciences 20: 1925.
'A small in vitro fermentation model for screening the gut microbiota effects of different fiber preparations ' () 20 International Journal of Molecular Sciences : 1925.
-
Van de Wiele, T., Van den Abbeele, P., Ossieur, W., Possemiers, S. and Marzorati, M., 2015. The simulator of the human intestinal microbial ecosystem (SHIME®). In: Verhoeckx, K., Cotter, P., López-Expósito, I., Kleiveland, C., Lea, T., Mackie, A., Requena, T., Swiatecka D. and Wichers, H. (eds.), The impact of food bioactives on health: in vitro and ex vivo models. Springer International Publishing, Berlin, Germany, pp. 305-317.
'The simulator of the human intestinal microbial ecosystem (SHIME®) ', () 305 -317.
-
Van den Abbeele, P., Belzer, C., Goossens, M., Kleerebezem, M., De Vos, W.M., Thas, O., De Weirdt, R., Kerckhof, F.M. and Van de Wiele, T., 2013. Butyrate-producing Clostridium cluster XIVa species specifically colonize mucins in an in vitro gut model. ISME Journal 7: 949-961.
'Butyrate-producing Clostridium cluster XIVa species specifically colonize mucins in an in vitro gut model ' () 7 ISME Journal : 949 -961.
-
Van den Abbeele, P., Grootaert, C., Marzorati, M., Possemiers, S., Verstraete, W., Gerard, P., Rabot, S., Bruneau, A., El Aidy, S., Derrien, M., Zoetendal, E., Kleerebezem, M., Smidt, H. and Van de Wiele, T., 2010. Microbial community development in a dynamic gut model is reproducible, colon region specific, and selective for Bacteroidetes and Clostridium cluster IX. Applied and Environmental Microbiology 76: 5237-5246.
'Microbial community development in a dynamic gut model is reproducible, colon region specific, and selective for Bacteroidetes and Clostridium cluster IX ' () 76 Applied and Environmental Microbiology : 5237 -5246.
-
Van den Abbeele, P., Roos, S., Eeckhaut, V., MacKenzie, D.A., Derde, M., Verstraete, W., Marzorati, M., Possemiers, S., Vanhoecke, B., Van Immerseel, F. and Van de Wiele, T., 2012. Incorporating a mucosal environment in a dynamic gut model results in a more representative colonization by lactobacilli. Microbial Biotechnology 5: 106-115.
'Incorporating a mucosal environment in a dynamic gut model results in a more representative colonization by lactobacilli ' () 5 Microbial Biotechnology : 106 -115.
-
Van den Abbeele, P., Taminiau, B., Pinheiro, I., Duysburgh, C., Jacobs, H., Pijls, L. and Marzorati, M., 2018. Arabinoxylo-oligosaccharides and inulin impact inter-individual variation on microbial metabolism and composition, which immunomodulates human cells. Journal of Agricultural and Food Chemistry 66: 1121-1130.
'Arabinoxylo-oligosaccharides and inulin impact inter-individual variation on microbial metabolism and composition, which immunomodulates human cells ' () 66 Journal of Agricultural and Food Chemistry : 1121 -1130.
-
Van Herreweghen, F., Van den Abbeele, P., De Mulder, T., De Weirdt, R., Geirnaert, A., Hernandez-Sanabria, E., Vilchez-Vargas, R., Jauregui, R., Pieper, D.H., Belzer, C., De Vos, W.M. and Van de Wiele, T., 2017. In vitro colonisation of the distal colon by Akkermansia muciniphila is largely mucin and pH dependent. Beneficial Microbes 8: 81-96.
'In vitro colonisation of the distal colon by Akkermansia muciniphila is largely mucin and pH dependent ' () 8 Beneficial Microbes : 81 -96.
-
Vanderhoof, J.A., Whitney, D.B., Antonson, D.L., Hanner, T.L., Lupo, J.V. and Young, R.J., 1999. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. Journal of Pediatrics 135: 564-568.
'Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children ' () 135 Journal of Pediatrics : 564 -568.
-
Wang, Q., Garrity, G.M., Tiedje, J.M. and Cole, J.R., 2007. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Applied and Environmental Microbiology 73: 5261-5267.
'Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy ' () 73 Applied and Environmental Microbiology : 5261 -5267.
-
White, A.R., Kaye, C., Poupard, J., Pypstra, R., Woodnutt, G. and Wynne, B., 2004. Augmentin® (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent. Journal of Antimicrobial Chemotherapy 53: i3-i20.
'Augmentin® (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent ' () 53 Journal of Antimicrobial Chemotherapy : i3 -i20.
Supplementary Materials
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 0 | 0 | 0 |
| Full Text Views | 1263 | 435 | 28 |
| PDF Views & Downloads | 1485 | 571 | 20 |
Lacticaseibacillus rhamnosus GG and Saccharomyces cerevisiae boulardii supplementation exert protective effects on human gut microbiome following antibiotic administration in vitro
In: Beneficial MicrobesSearch for other papers by C. Duysburgh in
Current site
Google Scholar
PubMed
Search for other papers by P. Van den Abbeele in
Current site
Google Scholar
PubMed
Search for other papers by M. Morera in
Current site
Google Scholar
PubMed
Center of Microbial Ecology and Technology (CMET), Ghent University, Coupure Links 653, 9000 Ghent, Belgium.
Search for other papers by M. Marzorati in
Current site
Google Scholar
PubMed
Antibiotic-induced dysbiosis of the microbial community has been associated with several gastrointestinal symptoms. The impact of repeated administration of Lacticaseibacillus rhamnosus GG (CNCM-I-4798) (formerly known as Lactobacillus rhamnosus GG), Saccharomyces cerevisiae boulardii (CNCM-I-1079) and their combination (associated in Smebiocta/Smectaflora Protect®) in supporting recovery of gut microbiota functionality and composition during and following amoxicillin:clavulanic acid administration was evaluated in vitro. Antibiotic dosage negatively affected SCFA production, coinciding with detrimental effects on Bacteroidetes, Firmicutes and Bifidobacterium spp. in the simulated proximal colon, while Akkermansia muciniphila was significantly reduced in the distal colon. L. rhamnosus GG and S. boulardii were able to thrive in both colon regions upon dosing, with S. boulardii even showing protective effects on the survival of L. rhamnosus GG during antibiotic administration. The impact of the probiotic strains on microbiome recovery revealed that supplementation with L. rhamnosus GG and/or S. boulardii resulted in a stimulating effect on the most abundant bacterial groups within the bacterial community of each donor. For one of the donors tested, co-dosing of L. rhamnosus GG and S. boulardii resulted in superior short-chain fatty acid recovery accompanied by a stronger increase in abundance of Bifidobacteriaceae. Overall, the current study provides first evidence that combined supplementation of L. rhamnosus GG and S. boulardii might be an interesting candidate in limiting detrimental effects of amoxicillin:clavulanic acid on the human gut microbiome, though further studies are warranted to confirm these findings.
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 0 | 0 | 0 |
| Full Text Views | 1263 | 435 | 28 |
| PDF Views & Downloads | 1485 | 571 | 20 |
